US financing body, Biological E finalise agreement to expand COVID manufacturing capabilities in India

Oct 25, 2021

Hyderabad (Telangana) [India], October 25 : In a move towards fulfilling the commitment set by the "Quad" leaders, the U.S. International Development Finance Corporation...

COVID-19: ICMR, Biological E develop 'Antisera' for virus cure, prevention

Oct 01, 2020

New Delhi [India], October 1 : As part of the global attempt to find a remedy for coronavirus, the Indian Council of Medical Research...

Biological E to amp up jab production with Rs 1,800-crore investment

Jul 22, 2022

Hyderabad (Telangana) [India], July 22 : As India is cementing Hyderabad's position as the "Vaccine Capital of the World", Biological E has announced its...

Biological E gets approval to conduct trials of Corbevax as booster dose

Dec 28, 2021

New Delhi [India], December 29 : The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to...

Biological E to submit final data on its COVID-19 vaccine Corbevax till November end: Sources

Oct 14, 2021

New Delhi [India], October 14 : Biological E will submit final data on COVID-19 vaccine Corbevax till November end, informed Government sources on Thursday.

Biological E gets DCGI's nod to manufacture, market 14-valent pneumococcal conjugate vaccine

Dec 16, 2022

Streptococcus pneumonia infection remains one of the leading causes of death among children under five in India and developing countries. BE's PCV14 Vaccine will...